U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Prediagnostic Adult Body Mass Index Change and Esophageal Adenocarcinoma Survival



Details

  • Personal Author:
  • Description:
    Background: We examined whether body mass index (BMI) changes in adulthood, prior to disease onset, are associated with overall survival among esophageal adenocarcinoma patients. Methods: We included 285 histologically confirmed patients with a complete baseline BMI questionnaire. Using extended Cox regression models, we obtained adjusted hazard ratios (HRs) for the associations between overall survival and BMI at diagnosis, BMI 6 months before diagnosis, self-reported average adult BMI, and deltaBMI (BMI 6 months before diagnosis minus average adult BMI), categorized into tertiles <0 kg/m2 (BMI loss), >/=0 and <1.25 kg/m2 (stable BMI), and >/=1.25 kg/m2 (BMI gain). We also assessed interaction between deltaBMI and average adult BMI (>/= kg/m2 versus <27.5 kg/m2) with overall survival. Results: Body mass index at diagnosis >25 and <35 kg/m2 was associated with better overall survival. Compared to patients with stable BMI in adulthood, patients who gained BMI throughout adulthood had 1.68 times the all-cause hazard of death (95% CI: 1.17-2.43; P < .01), independent of diagnosis BMI and percent weight loss 6 months before diagnosis. Compared to patients with average adult BMI < 27.5 who maintained stable adult BMI, patients with average adult BMI >/= 27.5 kg/m2 who gained BMI had the worst survival (HR = 3.05; 95% CI 1.62-5.72; P < .01). Conclusion: Body mass index gain in adulthood is associated with poor overall survival, and maintaining a normal body weight throughout adulthood is associated with the best overall survival among esophageal adenocarcinoma patients, independent of BMI at diagnosis. [Description provided by NIOSH]
  • Subjects:
  • Keywords:
  • ISSN:
    2045-7634
  • Document Type:
  • Funding:
  • Genre:
  • Place as Subject:
  • CIO:
  • Topic:
  • Location:
  • Volume:
    9
  • Issue:
    10
  • NIOSHTIC Number:
    nn:20059052
  • Citation:
    Cancer Med 2020 May; 9(10):3613-3622
  • Contact Point Address:
    Elizabeth A. Loehrer, Department of Environmental Health, Harvard T.H. Chan School of Public Health, 665 Huntington Ave, Boston, MA 02115, USA
  • Email:
    eal405@mail.harvard.edu
  • Federal Fiscal Year:
    2020
  • Performing Organization:
    Harvard School of Public Health
  • Peer Reviewed:
    True
  • Start Date:
    20050701
  • Source Full Name:
    Cancer Medicine
  • End Date:
    20280630
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:e216a649ce6112272ea16b0897f878b913775d53b67f59e206477e1b707295692ee9a4c77896691b7e0f0c27e47d5edaa29fb3f25438fbf60a4312db01f80e58
  • Download URL:
  • File Type:
    Filetype[PDF - 331.25 KB ]
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.